老百姓:老百姓2025年一季度报告(英文版)

Stock Code: 603883 Stock Abbreviation: LBX
LBX Pharmacy Chain Joint Stock Company
2025 First Quarter Report
The Company's Board of Directors and all directors undertake that nothing hereof contains any
false records, misleading representations or major omissions, and are legally liable for authenticity,
accuracy and integrity of the contents hereof.
Important Notes
The Company's Board of Directors, Board of Supervisors, and directors, supervisors, and senior executives
guarantee that the content of the quarterly report is true, accurate, and complete, contains no false records,
misleading statements, or material omissions, and bear individual and joint legal liabilities.
The Company's principal, person in charge of accounting work, and person in charge of accounting department
(chief accountant) guarantee that the financial information in the quarterly report is true, accurate, and
complete.
Whether the first quarter financial statements have been audited
□Yes √No
I. Main Financial Data
(I) Main Accounting Data and Financial Indicators
Unit: Yuan Currency: RMB
Same period of previous Increase/decrease on
Item Current reporting period year a year-on-year basis
(%)
Operating income 5,435,220,089 5,539,130,441 -1.88
Net profit attributable to
shareholders of the listed 250,636,310 321,257,612 -21.98
company
Net profit attributable to
shareholders of the listed 243,498,304 310,558,626 -21.59
company after deducting
non-recurring gains and losses
Net cash flows from operating 804,266,875 417,071,839 92.84
activities
Basic EPS (RMB/share) 0.33 0.42 -21.43
Diluted EPS (RMB/share) 0.33 0.42 -21.43
Weighted average ROE (%) 3.74 4.68 Decrease by 0.94PP

percentage points
End of the reporting Increase/decrease on
period End of the previous year a year-on-year basis
(%)
Total asset 21,032,492,621 21,044,853,679 -0.06
Owner's equity attributable to
shareholders of the listed 6,831,826,301 6,580,857,270 3.81
company
Non-recurring gains and losses items and amounts
√Applicable □Not Applicable
Unit: Yuan Currency: RMB
Non-recurring gains and losses item Amount of the current Explanation
period
Gains or losses from disposal of non-current assets,
including the write-off portion of asset impairment -757,855
provisions already recognized
Government grants recognized in current profit or loss,
excluding those closely related to the Company's
normal business operations, complying with national 8,051,561
policy regulations, enjoyed according to established
standards, and having a continuous impact on the
Company's profit or loss
Gains or losses from changes in fair value of financial
assets and liabilities held by non-financial enterprises,
and gains or losses from disposal of financial assets 350,315
and liabilities, excluding effective hedging activities
related to the Company's normal business operations
Fees charged for the occupation of funds to
non-financial enterprises recognized in current profit
or loss
Gains or losses from entrusting others to invest or
manage assets
Gains or losses from external entrusted loans
Asset losses arising from force majeure factors, such as
natural disasters
Reversal of impairment provisions for receivables
tested individually for impairment
Gains arising from the investment cost of acquiring
subsidiaries, associates, and joint ventures being less
than the fair value of the identifiable net assets of the
investee at the time of acquisition
Current net profit or loss of subsidiaries from the
beginning of the period to the merger date arising from
business combinations involving enterprises under
common control
Gains or losses from non-monetary asset exchanges
Gains or losses from debt restructuring
One-off expenses incurred due to the discontinuation
of related business activities,